 |
Top 53 medical and healthcare startups in Australia
Oct 24, 2024 | By Jason Kwon | 20 |
1
Funding: $62.4M
Botanix Pharmaceuticals intends to improve the lives of patients suffering from serious skin diseases including acne, psoriasis and atopic dermatitis using a novel therapeutic and advanced transdermal drug delivery system.
Botanix Pharmaceuticals intends to improve the lives of patients suffering from serious skin diseases including acne, psoriasis and atopic dermatitis using a novel therapeutic and advanced transdermal drug delivery system.
2
Funding: $3M
SYMBYX develops laser light therapy devices to promote wellness and help manage symptoms of chronic conditions. such as Parkinson's, IBD/IBS, Arthritis, Chronic Pain and more.
SYMBYX develops laser light therapy devices to promote wellness and help manage symptoms of chronic conditions. such as Parkinson's, IBD/IBS, Arthritis, Chronic Pain and more.
3
Funding: $21.4M
ANDHealth is an integrated ecosystem for the development & commercialisation of evidence-based digital health products.
ANDHealth is an integrated ecosystem for the development & commercialisation of evidence-based digital health products.
4
Funding: $145M
Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic.
Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic.
6
Funding: $121.1M
Harrison.ai is a clinician-led healthcare AI company using deep learning to improve the odds of IVF success for thousands of patients.
Harrison.ai is a clinician-led healthcare AI company using deep learning to improve the odds of IVF success for thousands of patients.
7
Funding: $102.5M
Vaxxas is pioneering a next-generation vaccine delivery platform that enables robust immune system activation by targeting vaccine components to the abundant immunological cells immediately below the surface of the skin. Vaxxas' proprietary Nanopatch technology aims to provide an optimized, differentiated needle-free vaccine delivery solution that safely and cost effectively amplifies vaccine efficacy.
Vaxxas is pioneering a next-generation vaccine delivery platform that enables robust immune system activation by targeting vaccine components to the abundant immunological cells immediately below the surface of the skin. Vaxxas' proprietary Nanopatch technology aims to provide an optimized, differentiated needle-free vaccine delivery solution that safely and cost effectively amplifies vaccine efficacy.
8
Funding: A$80M
Imugene is a publicly-listed biotechnology company with operations in America and Europe,
Imugene is a publicly-listed biotechnology company with operations in America and Europe,
9
Funding: $57M
PainChek is transforming pain management to help give a voice to those who cannot verbalise their pain.
PainChek is transforming pain management to help give a voice to those who cannot verbalise their pain.
10
Funding: A$55M
Prospection develops and deliver world class consulting, data and technology solutions across the healthcare sector, with a focus on the supply and use of medications.
Prospection develops and deliver world class consulting, data and technology solutions across the healthcare sector, with a focus on the supply and use of medications.
11
Funding: $28.6M
Revolutionising healthcare through real-time remote biomarker monitoring devices
Revolutionising healthcare through real-time remote biomarker monitoring devices
13
Funding: A$26.5M
MedAdvisor International develops software for personal medication management.
MedAdvisor International develops software for personal medication management.
14
Funding: AUD$34M
Seer is a medical technology company that specializes in addressing neurological conditions. It created at-home electroencephalograph (EEG) system, Seer Home, which helps providers diagnose epilepsy.
Seer is a medical technology company that specializes in addressing neurological conditions. It created at-home electroencephalograph (EEG) system, Seer Home, which helps providers diagnose epilepsy.
15
Funding: $20.8M
Global Kinetics Corporation develops movement recording tool for neurologists in the management of Parkinson’s disease.
Global Kinetics Corporation develops movement recording tool for neurologists in the management of Parkinson’s disease.
16
Funding: $19.7M
Mindset Health helps improve recurring health issues like irritable bowel syndrome and anxiety with app-based hypnotherapy.
Mindset Health helps improve recurring health issues like irritable bowel syndrome and anxiety with app-based hypnotherapy.
17
Funding: $18M
Bionic Vision Technologies develops visual prostheses to restore vision to the blind. The devices operate by electrically stimulating the remaining retinal cells in patients with retinal degeneration.
Bionic Vision Technologies develops visual prostheses to restore vision to the blind. The devices operate by electrically stimulating the remaining retinal cells in patients with retinal degeneration.
18
Funding: $17.1M
OncoRes Medical develops an imaging technology to provide intraoperative information available to breast cancer surgeons.
OncoRes Medical develops an imaging technology to provide intraoperative information available to breast cancer surgeons.
19
Funding: A$20M
Updoc is an online health platform that helps users to have confidential consultations with registered Australian doctors.
Updoc is an online health platform that helps users to have confidential consultations with registered Australian doctors.
20
Funding: $10M
Endogene has developed a self-advancing single-use gastrointestinal endoscope platform. Provides safe, timely, relaible and cost-effective access to entire GI tract. Advanced 4k imaging and AI-assisted diagnose.
Endogene has developed a self-advancing single-use gastrointestinal endoscope platform. Provides safe, timely, relaible and cost-effective access to entire GI tract. Advanced 4k imaging and AI-assisted diagnose.
